{"id":"https://openalex.org/W2008595453","doi":"https://doi.org/10.5414/cnp73139","title":"Renoprotective effects of telmisartan in patients with advanced chronic kidney disease","display_name":"Renoprotective effects of telmisartan in patients with advanced chronic kidney disease","publication_year":2010,"publication_date":"2010-02-01","ids":{"openalex":"https://openalex.org/W2008595453","doi":"https://doi.org/10.5414/cnp73139","mag":"2008595453","pmid":"https://pubmed.ncbi.nlm.nih.gov/20129021"},"language":"en","primary_location":{"id":"doi:10.5414/cnp73139","doi":"https://doi.org/10.5414/cnp73139","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cnp73139","pdf_url":null,"source":{"id":"https://openalex.org/S16687455","display_name":"Clinical Nephrology","issn_l":"0301-0430","issn":["0301-0430"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110291303","display_name":"Masaki Tokunaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188700360","display_name":"University of Occupational and Environmental Health Japan","ror":"https://ror.org/020p3h829","country_code":"JP","type":"education","lineage":["https://openalex.org/I188700360"]},{"id":"https://openalex.org/I4405282803","display_name":"Hospital of the University of Occupational and Environmental Health","ror":"https://ror.org/00fv5dt23","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405282803"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Tokunaga","raw_affiliation_strings":["Kidney Center, University of Occupational and Environmental Health University Hospital, Kitakyushu, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kidney Center, University of Occupational and Environmental Health University Hospital, Kitakyushu, Japan","institution_ids":["https://openalex.org/I188700360","https://openalex.org/I4405282803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105417359","display_name":"Narutoshi Kabashima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Kabashima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018524876","display_name":"Ryota Serino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Serino","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"T. Shibata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Shibata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108585984","display_name":"Mayumi Matsumoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Matsumoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"T. Miyamoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Miyamoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088518123","display_name":"Mariko Miyazaki","orcid":"https://orcid.org/0000-0001-6509-1706","observed_orcids":["https://orcid.org/0000-0001-6509-1706"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Miyazaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083286581","display_name":"Yumi Furuno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Furuno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082321456","display_name":"J. Nakamata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Nakamata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102952464","display_name":"Yuki Fujimoto","orcid":"https://orcid.org/0000-0003-0095-9580","observed_orcids":["https://orcid.org/0000-0003-0095-9580"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Fujimoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M. Takeuchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Takeuchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074133353","display_name":"Hiroshi Abe","orcid":"https://orcid.org/0009-0006-6343-7199","observed_orcids":["https://orcid.org/0009-0006-6343-7199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Abe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089502824","display_name":"Masahiro Okazaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Okazaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031020219","display_name":"Yoshihito Otsuji","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Otsuji","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111960410","display_name":"Misato Tamura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Tamura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7353,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.74677624,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"73","issue":"02","first_page":"139","last_page":"146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.034299999475479126,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/telmisartan","display_name":"telmisartan","score":1.0},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.949999988079071},{"id":"https://openalex.org/keywords/advanced-chronic-kidney-disease","display_name":"advanced chronic kidney disease","score":0.9490000009536743},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.9539999961853027},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.8999999761581421},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate-decline","display_name":"estimated glomerular filtration rate decline","score":0.8569999933242798},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.949999988079071},{"id":"https://openalex.org/keywords/renal-replacement-therapy","display_name":"renal replacement therapy","score":0.9419999718666077},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8100000023841858},{"id":"https://openalex.org/keywords/hyperkalemia","display_name":"hyperkalemia","score":0.7319999933242798},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9543983936309814},{"id":"https://openalex.org/C2779716603","wikidata":"https://www.wikidata.org/wiki/Q733186","display_name":"Telmisartan","level":3,"score":0.9282508492469788},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.8058182001113892},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.7589551210403442},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.6768364310264587},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6263565421104431},{"id":"https://openalex.org/C2780243291","wikidata":"https://www.wikidata.org/wiki/Q605259","display_name":"Hyperkalemia","level":2,"score":0.6109381914138794},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.5453069806098938},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5069068074226379},{"id":"https://openalex.org/C2779541074","wikidata":"https://www.wikidata.org/wiki/Q185643","display_name":"Renal replacement therapy","level":2,"score":0.49880552291870117},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.49600061774253845},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4219728112220764},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4136938750743866},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.3451833128929138},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.24634456634521484},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077333","descriptor_name":"Telmisartan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.5414/cnp73139","doi":"https://doi.org/10.5414/cnp73139","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cnp73139","pdf_url":null,"source":{"id":"https://openalex.org/S16687455","display_name":"Clinical Nephrology","issn_l":"0301-0430","issn":["0301-0430"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Nephrology","raw_type":"journal-article"},{"id":"pmid:20129021","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20129021","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical nephrology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1982069264","https://openalex.org/W2534598972","https://openalex.org/W3109106979","https://openalex.org/W2243349785","https://openalex.org/W1928353480","https://openalex.org/W2064504656","https://openalex.org/W2031053334","https://openalex.org/W2127808551","https://openalex.org/W2023878393","https://openalex.org/W2002381859"],"abstract_inverted_index":{"BACKGROUND:":[0],"Angiotensin":[1],"II":[2],"receptor":[3],"blockers":[4],"(ARBs)":[5],"provide":[6],"renoprotective":[7],"effects":[8],"in":[9,31,51,159,202,214,233,243],"patients":[10,32,39,83,145,157,244],"with":[11,33,40,87,155,197,230,245],"mild-to-moderate":[12],"chronic":[13],"kidney":[14,100,234],"disease":[15,108],"(CKD).":[16],"However,":[17],"there":[18],"have":[19],"been":[20],"few":[21],"reports":[22],"regarding":[23],"whether":[24],"ARBs":[25,48,88],"show":[26],"clinical":[27],"efficacy":[28],"and":[29,54,102,114,194],"safety":[30],"advanced":[34,246],"CKD.":[35,247],"METHODS:":[36],"Seventy-two":[37],"hypertensive":[38],"Stages":[41],"3":[42],"-":[43,170],"4":[44],"CKD":[45],"receiving":[46],"no":[47],"were":[49,84,116,124,147],"enrolled":[50],"this":[52],"study":[53],"observed":[55],"up":[56],"to":[57,63,149,184,224],"48":[58],"months.":[59],"Telmisartan":[60,175],"was":[61,195,217],"added":[62],"conventional":[64,225],"antihypertensive":[65,226],"agents":[66],"(n":[67,89],"=":[68,90],"36,":[69,91],"mean":[70,92],"estimated":[71],"glomerular":[72],"filtration":[73],"ratio":[74],"[eGFR]":[75],"19.7":[76],"ml/min/1.73":[77,95],"m2)":[78],"whilst":[79],"the":[80,103,127,130,141,160,203],"remaining":[81],"control":[82,161],"not":[85],"treated":[86],"eGFR":[93],"19.2":[94],"m2).":[96],"Urinary":[97],"protein":[98],"excretion,":[99],"function,":[101],"occurrence":[104],"of":[105,121,133,200,206,210,222,239],"end-stage":[106],"renal":[107,110,150],"requiring":[109],"replacement":[111,151],"therapy,":[112,152],"hyperkalemia,":[113],"death":[115],"analyzed.":[117],"RESULTS:":[118],"Baseline":[119],"characteristics":[120],"each":[122,134],"group":[123,135,162],"similar.":[125,218],"During":[126],"observation":[128],"period,":[129],"blood":[131],"pressures":[132],"decreased":[136],"at":[137],"similar":[138],"rates.":[139],"In":[140],"telmisartan":[142,223],"group,":[143],"17":[144],"(47.2%)":[146],"introduced":[148],"as":[153],"compared":[154],"31":[156],"(86.1%)":[158],"(relative":[163],"risk":[164],"0.55,":[165],"95%":[166],"confidence":[167],"interval":[168],"0.19":[169],"0.92,":[171],"p":[172,191],"<":[173,192],"0.05).":[174],"significantly":[176],"reduced":[177],"proteinuria":[178],"levels":[179],"(from":[180],"3.47":[181],"+/-":[182,186],"3.00":[183],"2.41":[185],"2.46":[187],"g/g":[188],".":[189],"creatinine,":[190],"0.05)":[193],"associated":[196,229],"a":[198],"reduction":[199],"49.6%":[201],"decline":[204],"rate":[205],"eGFR.":[207],"The":[208,220],"incidence":[209,238],"major":[211],"adverse":[212,240],"events":[213],"both":[215],"groups":[216],"CONCLUSIONS:":[219],"addition":[221],"therapy":[227],"is":[228],"significant":[231],"improvement":[232],"outcome":[235],"without":[236],"increased":[237],"effects,":[241],"even":[242]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}